ArticleCureus2025
Outcomes Following the Arthroscopic Chondro-Gide Repair of Osteochondral Defects of the Talus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Osteochondral defects (OCD) of the talus are associated with pain and ankle joint dysfunction. Autologous matrix-induced chondrogenesis (AMIC) is one of the arthroscopic surgical techniques described for the treatment of talar OCD. There is scarce evidence regarding the use of Chondro-Gide or any other synthetic matrix for OCD of the talus. We aimed to investigate patient outcomes following Chongro-Gide repair of talar OCDs, along with the relationship between lesion diameter and patient outcomes. Methods A retrospective cross-sectional study was carried out, and patient outcomes were recorded. Olerud-Molander Ankle Score (OMAS) was documented for each patient during clinic follow-ups, as well as visual analogue scores (VAS). Both preoperative and postoperative OMAS and VAS scores were recorded at the 12-week postoperative follow-up. The other factors recorded were as follows: lesion size, site of OCD, postoperative complications, patient age, and gender. Results Sixteen patients were identified with isolated talus OCD. The mean preoperative OMFAS was 30 (range: 10-45) while the postoperative OMAS was 72.7 (range: 65-100, p<0.01). The mean VAS score was 7.85 preoperatively compared to 2.69 postoperatively (p<0.01). The average OCD diameter was 8.9 mm (range: 3-14). There was no statistically significant correlation between OCD lesion diameter and improvement in OMAS scores (p>0.05). The most commonly reported complication by patients was postoperative stiffness. Conclusions We observed positive outcomes following arthroscopic osteochondral lesion repair using AMIC Chondro-Gide. While there is a paucity of evidence on the use of AMIC to treat talar OCDs, our study adds to the growing evidence endorsing arthroscopic AMIC with Chondro for treating talar OCDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.